Phibro Animal Health Corp's revenue was $1.52bn in fiscal 2026, up 17.1% on the year before. Since fiscal 2012 ($654m) it has grown at a compound 6.2% a year.
Revenue history
US$ millions unless shown otherwise.
Fiscal years, plus the last twelve months (LTM) when newer.
Phibro Animal Health Corp: revenue history, annual
Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.
Where the revenue comes from
Fiscal year to June 30, 2026
Animal Health$1.2B
Mineral Nutrition$282M
Performance Products$73.5M
Segments
Line of business
Revenue
Share
YoY
Animal Health
$1.2B
76.6%
▲ 20.7%
Mineral Nutrition
$282M
18.6%
▲ 11.5%
Performance Products
$73.5M
4.8%
▼ 8.3%
Animal Health$1.2B
Mineral Nutrition$282M
Performance Products$73.5M
Products and services
Line of business
Revenue
Share
YoY
Animal Health
$1.2B
76.6%
▲ 20.7%
↳ Medicated Feed Additives and Others (part of Animal Health)
$811M
69.8%
▲ 25.4%
↳ Nutritional Specialties (part of Animal Health)
$195M
16.8%
▲ 8.8%
↳ Vaccines (part of Animal Health)
$156M
13.5%
▲ 14.0%
Mineral Nutrition
$282M
18.6%
▲ 11.5%
Performance Products
$73.5M
4.8%
▼ 8.3%
United States$877M
Latin America and Canada$341M
EMEA$188M
Asia Pacific$112M
Geography
Region
Revenue
Share
YoY
United States
$877M
57.8%
▲ 18.5%
Latin America and Canada
$341M
22.4%
▲ 14.1%
EMEA
$188M
12.4%
▲ 17.3%
Asia Pacific
$112M
7.4%
▲ 15.3%
From Phibro Animal Health Corp's 10-K filed August 26, 2026, as tagged in the filing.
View filing. Indented rows are part of the
line above; their share is of that line. In the bars, the
faint bar behind is the year before.
Revenue against peers
Pharmaceuticals: the closest covered companies by revenue. Last twelve months.
